目前乳腺癌的鉴别有三个步骤，即筛查试验、诊断试验和监测试验。如果公众有罹患癌症的风险，就会接受甄别测试，以确定他们的身分。这不是一种精确的方法，但它是一种用于检测任何异常或任何细胞质量的初步筛选试验。它们被称为临床乳房检查。建议20 – 30岁的女性至少每3年进行一次临床乳房检查。建议40岁以上的女性每年进行乳房x光检查。通过对乳腺细胞异常生长的分析，对乳腺癌进行准确的诊断和确证。对于诊断学，规定了一系列检测癌症是否存在的测试。最准确的检查之一是使用活检。活检被用来诊断乳腺癌。已经发现，早期诊断的条件，导致更容易纠正的问题。除了Clood细胞计数，生物标记、骨标记、血液化学、血液MRI、胸部x射线、导管冲洗、鱼类检查、ISc检查、乳房x线摄影、分子乳房成像、超声波、Pet扫描、热像仪是其他一些诊断测试，用于识别和监测癌症的进展。发展为乳腺癌的妇女在晚期被确诊时死亡率更高。人们一旦患上癌症，存活率就会非常低。据观察，它与已确定的阶段直接相关。肺癌被认为是死亡率较高的癌症，其次是乳腺癌。乳腺癌V期生存率高达93%。但是第四阶段的存活率是15%。死亡率高的原因是癌细胞的转移。这也表明了在更早的阶段识别乳腺癌的迫切需要。提供治疗后，监测测试用于确定疾病的进展情况。如果癌症再次发展或复发，监测测试可用于确定癌症的进展。
There are currently three processes followed to identify breast cancer, namely, the screening test, diagnostic test and monitoring tests. Screening tests are given to the general public to identity if they are at risk for developing cancer. It is not an accurate method but it is an initial screening test that is used to detect any abnormality or any cell mass. They are known as clinical breast exam. Clinical breast exam is suggested at least every 3 years for women aged 20s and 30s. Annual mammographic screening is advised for women in their 40s and older. Accurate determination of breast cancer and confirmation is done through analysis of the abnormal cell growth in breast. For Diagnostics, a range of tests are prescribed to detect the presence of Cancer. One of the most accurate tests is the use of Biopsy. Biopsy is used to diagnose breast cancer. It has been found that early diagnosis of the condition leads to easier rectification of the issues. Apart from this Clood cell count, Bio markers, bone markers, blood chemistry, blood MRI, Chest xrays, ductal lavage, FISH tests, ISc test, Mammogram, Molecular breast imaging, ultrasounds, Pet Scans, Thermography are some of the other diagnostic tests that are used to identify and monitor the progression of cancer. Women who have developed breast cancer have higher rates of mortality when they are identified at a later stage. The survival rate of people once they had developed Cancer is very less. It has been observed that it is directly related to the stage at which it has been identified. Lung Lunger Cancer has been identified as the higher mortality rate that is followed by Breast Cancer. The Stage V breast cancer survival rate is as high as 93%. But the survival rate for stage IV is 15% . The reason for the high mortality rates is due to metastasis of cancer cell. This also shows the imperative need for identifying breast cancer at a much earlier stage. After providing treatment, monitoring tests are used to identify about the progression of the disease. If the cancer develops again or relapses, the monitoring tests can be used to identify the progression of the cancer.